Company Filing History:
Years Active: 2025
Title: Innovations in Cancer Treatment by Felipe Nunez
Introduction
Felipe Nunez is an accomplished inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer treatment through his innovative work on therapeutic protein-based nanoparticles. His research focuses on developing advanced methods for treating intracranial tumors, showcasing his commitment to improving patient outcomes.
Latest Patents
Felipe Nunez holds a patent for "Therapeutic protein-based nanoparticles for treating cancer." This patent describes a novel approach using protein-based nanoparticles characterized by their ability to treat cancer, particularly intracranial tumors. The nanoparticles are composed of a water-soluble protein with an average molecular weight ranging from ≥about 8 kDa to ≤about 700 kDa. In certain variations, these proteins are cross-linked and form a mesh structure with an average linear mesh size between ≥about 1 nm to ≤about 4 nm. Additionally, the nanoparticles may incorporate a transcription factor, such as a therapeutic nucleic acid, within the mesh structure. The methods for creating these nanoparticles involve jetting a liquid containing the water-soluble protein through a nozzle and exposing it to an electric field to solidify the liquid.
Career Highlights
Felipe Nunez is affiliated with the University of Michigan, where he continues to advance his research in nanotechnology and cancer treatment. His work has garnered attention for its potential to revolutionize therapeutic approaches in oncology. With a focus on innovative solutions, Nunez is dedicated to pushing the boundaries of current medical practices.
Collaborations
Felipe collaborates with esteemed colleagues, including Joerg Lahann and Nahal Habibi. Their combined expertise enhances the research efforts at the University of Michigan, fostering an environment of innovation and discovery.
Conclusion
Felipe Nunez's contributions to the field of cancer treatment through his patented innovations in protein-based nanoparticles highlight his role as a leading inventor. His work not only showcases the potential of nanotechnology in medicine but also emphasizes the importance of collaboration in advancing scientific research.